Revolutionary approach for evolutionary research

The most important lesson learnt from previous experience is consistency of delivery through transparent engaged conversations with our clients, especially in contract research. Research is consistently challenging, the last 18 months and COVID-19 is proof of that, but through open conversations, guiding through expertise, we will grow confidence in our client relationships. Most organisations see one light, provide one solution. Tigermed sees many different rays, many different solutions to discuss and work with our clients to meet their needs.

The long-term pandemic impact
In Europe, countries responded to the pandemic based on their financial capacity and health system capability. This meant variability in clinical research response to COVID-19 and support for non-COVID-19 studies. As Europe slowly emerges as the vaccines are rolled out, the legacy to both our health services and research studies is emerging.

Moving forward, COVID-19 will be seen as transformational in the way we deliver clinical research. We might see a significantly greater willingness of the regulatory authorities to both license earlier and ask for RWE studies to support results, thus accelerating drug development.

Breaking with traditions
Research, in fact, medicine, was incredibly traditional in its approach. Relationships built over decades often end despite the performance of CROs for Pharma – a ‘better the devil you know’ approach that still surprises when we get the same results though wish for something different!
To enter this world stage, Tigermed creates differentiated service offerings and progressively builds confidence with our clients on what we can deliver on our promises. So, whenever our clients are evolutionary in their development, we can be revolutionary in our approach. We show them distinctive ways and tailored solutions to meet their requirements – in partnership not ‘in hope’.

Tailoring to global Needs
As a contract research organization, the first question we need to understand is, what is the client’s top priority? Timing, quality, cost, often all of them. The tailored solution is listening to our clients, ascertaining that need, advising the client, and providing solutions that we jointly agree can be delivered in the time we promise. This approach isn’t new, it’s not groundbreaking; the difference, at Tigermed, is lived, not just stated.

Expansion to EU, Africa and more
We think about solutions globally rather than regionally because research is global. At all times, Tigermed acts as a global ‘trusted partner’. We established a delivery mechanism to support our global vision and seamlessly integrated that into our solutions. As a result, we can deliver clinical research in Europe and beyond and hope to make Chinese companies see Europe and Africa as their next destination of choice, not as Europe but as an extension of what Tigermed can do for them. Truly One global Tigermed, one global standard of delivery.